Gritstone Bio - Stock Price History | GRTS
Historical daily share price chart and data for Gritstone Bio since 2022 adjusted for splits. The latest closing stock price for Gritstone Bio as of August 12, 2022 is 4.10.
- The all-time high Gritstone Bio stock closing price was 31.10 on December 06, 2018.
- The Gritstone Bio 52-week high stock price is 14.42, which is 251.7% above the current share price.
- The Gritstone Bio 52-week low stock price is 1.71, which is 58.3% below the current share price.
- The average Gritstone Bio stock price for the last 52 weeks is 6.49.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Gritstone Bio Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2021 |
10.7689 |
4.0700 |
27.1100 |
4.0700 |
12.8600 |
226.40% |
| 2020 |
5.4383 |
8.1300 |
11.3000 |
2.5700 |
3.9400 |
-56.08% |
| 2019 |
10.7768 |
16.2900 |
18.9600 |
7.0700 |
8.9700 |
-41.94% |
| 2018 |
19.0064 |
14.2400 |
31.1000 |
11.6100 |
15.4500 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.299B |
$0.048B |
|
Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company has built its tumor-specific immunotherapy approach on two key pillars - first, a proprietary machine learning-based platform, Gritstone EDGE(TM), which provides a powerful ability to predict from a routine tumor biopsy the tumor-specific neoantigens, or TSNA, that are presented on a patient?s tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patients? TSNA to drive the patient?s immune system to attack and destroy tumors.
|
